AML Versus MDS - What's Your Vision?

The WHO updated its definitions of myeloid malances. Patients with above 10% BLAST pretty much all behave like AML, he says. The idea is to allow such patients to be eligible for treatment or put on clinical trials depending on what seems best for that patient.